American Pathway Fixed 7 (MVA) review

Yes, for the buyer it's built for. If you want a seven-year rate lock, don't expect to need more than the free-withdrawal amount in any given year, and like the idea of a no-cost care waiver riding along in case health changes down the road, this is a reasonable contract. It's a weaker fit if you're rate-shopping strictly on yield — some seven-year MYGAs on the market right now guarantee meaningfully more — or if you think there's a real chance you'll need a large lump sum before the term is up, since that's exactly when the MVA bites.

The core appeal here is certainty plus flexibility around the edges. You lock a rate for seven years, so there's no guessing about what the account will be worth on a given anniversary. Layered on top of that is a free-withdrawal allowance that's more generous than a lot of seven-year MYGAs offer — 15% a year with a one-year carryover feature that can push a single year's allowance to 20% — plus RMDs that come out with no charge or MVA at all. The chronic illness and terminal illness waivers add a layer of protection that costs nothing extra, which matters if health becomes a factor mid-contract.

I think this product is best for someone in their 60s or 70s parking non-immediate-need money for seven years — often an IRA rollover or a maturing CD or annuity — who wants predictable growth and values the built-in care provisions more than they value squeezing out the last quarter-point of rate. It's less suited to someone chasing the highest possible guaranteed yield, since Corebridge's current rate here isn't the strongest in the seven-year MYGA field, and it's not a fit for anyone who anticipates needing a withdrawal larger than the free amount in the first few years, given the MVA exposure.

Strip away the brand name and this is a fixed-rate insurance contract: you hand over a lump sum, the carrier guarantees a stated rate for seven years, and at the end of the term your account is worth the premium plus seven years of compounded interest (minus any withdrawals taken). What you're actually paying for beyond the rate itself is the packaged protection — a free-withdrawal allowance well above the industry-typical 10%, a death benefit that bypasses surrender charges and MVA entirely, and no-cost riders that waive surrender charges if you're diagnosed with a terminal illness or need extended care. None of that shows up as a headline number, but it's real value if you ever need to use it.

The current declared rate is 4.40% for premiums under $100,000 and 4.60% for premiums of $100,000 or more, guaranteed for the full seven-year term (this is a snapshot as of the brochure date and will move with the current rate environment — always confirm the live rate before applying). After the seventh year, the contract renews at a new declared rate set annually, which by contract terms can never fall below the guaranteed minimum. There's also an optional return-of-premium guarantee available at issue: electing it means the contract is guaranteed to be worth at least the premium paid (less withdrawals) if surrendered, in exchange for a slightly lower initial rate. That's a real tradeoff worth thinking through — you're paying for a guarantee against loss of principal on a product that, without the MVA, would already return principal plus interest at maturity.

The extended care, terminal illness, and activities-of-daily-living waivers are the feature that separates this from a plain-vanilla MYGA. They're included automatically at no charge (though not available in every state) and waive the surrender charge and MVA if you qualify — meaning a health event that would otherwise trap your money behind a penalty instead lets you access it in full. For a buyer in the age range this product typically attracts, that's not a hypothetical. It's a meaningful piece of downside protection that a lot of competing MYGAs charge for or don't offer at all.

This is a seven-year commitment, and the surrender schedule reflects that: 9%, 8%, 7%, 6%, 5%, 4%, then 2% in the final year (note the schedule steps from 4% straight to 2%, skipping 3% — that's how Corebridge structured it, not a typo). Inside those limits, the free-withdrawal terms are genuinely above average — 15% of the prior anniversary value each year, with up to 5% of unused capacity carrying forward to raise the following year's allowance to 20%. RMDs tied solely to this contract can be taken at any time without a surrender charge or MVA, which matters for IRA money.

The market value adjustment is the part that needs the clearest explanation. It applies to any withdrawal or full surrender that exceeds the free amount during the seven-year period. In plain terms: if interest rates have risen since you bought the contract, the MVA will typically reduce what you receive on an early exit, because the insurer is effectively selling the underlying bonds backing your contract at a loss to fund your withdrawal. If rates have fallen since issue, the MVA can work in your favor and add to what you receive. Either way, it's a variable you don't control, tied to the broader rate environment rather than anything about your specific contract. Annuitization is available with no surrender charge or MVA starting three years after issue, which is one way to access the money penalty-free before the full term ends if that path fits your needs.

There's no base contract fee and no charge for the chronic illness or terminal illness waiver riders — those come standard. The real cost of this product isn't a line-item fee; it's opportunity cost and MVA exposure. The 4.40%/4.60% guaranteed rate is solid but not the most competitive rate available in the seven-year MYGA category right now, so a buyer prioritizing yield above all else should shop the current market before committing. And because the MVA applies to any above-free withdrawal for the full seven years, this isn't a contract to fund with money you might need access to in a size larger than the free-withdrawal allowance. The optional return-of-premium guarantee is worth weighing carefully — it trades a slightly lower rate for a guarantee that, in most rate environments, you'd likely get anyway by simply holding to maturity.

Legal Entity: American General Life Insurance Company

Parent: Corebridge Financial, Inc.

A.M. Best Rating: A